[Cultivate Knowledge, Cultivate Health 📚] A new concept of health and well-being, particularly for older people, has been emerging in recent years: healthy aging. Have you ever heard of it? Healthy aging means the optimisation of opportunities at all levels (healthcare, social, cultural, sporting...) to improve the health and quality of life of the elderly. In this perspective - in addition to longevity - vitality, intended as full participation in society, has become of great importance. #IBSA #CaringInnovation #CultivateKnowledgeCultivateHealth
Info
IBSA Institut Biochimique SA is a privately owned pharmaceutical company founded in Lugano in 1945. It started to develop its specific identity in 1985, when the current management took over, redefining its strategy and focusing on developing technologies that improve the quality of existing therapeutic solutions. Today, it is present on 5 continents and over 90 countries. The Group now counts on 20 subsidiaries in Europe, China and USA, and boasts a product portfolio covering 10 therapeutic areas. The company employs over 2,300 people, distributed among its headquarters, subsidiaries and manufacturing sites. IBSA is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products. Therapeutic areas: 🔹 Reproductive Medicine 🔹 Endocrinology 🔹 Pain and Inflammation 🔹 Osteoarticular 🔹 Aesthetic Medicine 🔹 Dermatology 🔹 Uro-gynaecology 🔹 Cardiometabolic 🔹 Respiratory 🔹 Consumer Health
- Website
-
http://www.ibsagroup.com/
Externer Link zu IBSA Group
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Lugano, Svizzera
- Art
- Privatunternehmen
- Spezialgebiete
- Pharmaceutical , Pharma Industry, R&D, cardiovascular, dermatology, dermoaesthetic, endocrinology, fertility, human reproduction, respiratory, rheumatology, pain, inflammation, urology und drugs
Orte
-
Primär
Via del Piano 29
Lugano, Svizzera CH-6915, CH
Beschäftigte von IBSA Group
Updates
-
The third appointment of the series dedicated to IBSA subsidiaries features IBSA Iberia. Launched shortly before the lockdown, the Spanish subsidiary had to face numerous challenges from the very beginning. However, as Felipe Hortelano Almeida, General Manager of IBSA Iberia, states: “This period put us to the test, but also highlighted our potential”. To date, in fact, IBSA Iberia is one of the most dynamic and high-performing companies in the panorama of IBSA’s subsidiaries, and is preparing to become a leading player in the Spanish pharmaceutical market, with a product portfolio that covers three therapeutic areas: aesthetic medicine, reproductive medicine and osteoarticular. 🔹 Read the story of IBSA Iberia in our latest news: https://lnkd.in/dweGKiXU #IBSA #CaringInnovation #WeAreIBSA
-
With #IBSAVoices also this month we explored a very current topic: generational differences in the workplace. Exploiting this diversity can create a more dynamic, creative and productive environment, capable of adapting to the challenges of the future. This time, we will listen to the perspective of Luca Fusetti, Junior Qualification & Validation Specialist, and Jessica Toth, Quality Documentation Officer, who will tell us their thoughts on this and other topics. 🔹 Watch the video and share your opinion too! #IBSA #CaringInnovation #WeAreIBSA
#IBSAVoices - Double Interview
-
What if you could ‘print’ your ideal meal? Science fiction becomes reality in Singapore! A novel 3D printer creates customised food, with tailored ingredients, texture and appearance. Special diets, specific nutritional requirements, new flavours: the possibilities are endless! 🔹 Find out more in the latest IBSA Foundation for scientific research blog article: https://lnkd.in/emHdSKMM Singapore University of Technology and Design (SUTD) #IBSA #CaringInnovation #ScienceBeyondFrontiers #IBSAFoundation #food #3Dprinting #technology
-
The 40th edition of the congress of European Society of Human Reproduction and Embryology (ESHRE) – a key event in the field of reproductive medicine – was held in Amsterdam from 7 to 10 July. IBSA took part in this event by organising two scientific sessions: one on the management of adenomyosis in #ART (Assisted Reproductive Technology) programmes and the other on the use of LH activity in various ovarian stimulation protocols. IBSA’s commitment in the field of fertility is relentless: we make our choices by putting patients first, and we support the importance of personalising therapeutic treatments based on the needs of each patient. 🔹 Find out all the details in our latest news: https://lnkd.in/dhgE6dav #IBSA #CaringInnovation #pharmaceutical #eshre2024 Dom de Ziegler, Ernesto Bosch Aparicio, Peter Humaidan, Juan A. García Velasco
The 40th edition of the ESHRE Annual Meeting
ibsagroup.com
-
The Class40 IBSA crossed the finish line of the Transat Québec Saint-Malo at 16:34 pm CEST on July 15, after 14 days and 20 hours of sailing, and over 2,800 miles covered. Sixth on arrival, seventh in the official ranking, this is a great result for IBSA and our skipper ALBERTO BONA, a result earned with courage and determination, in a regatta that proved to be much more complex than expected and is already legendary. Congratulations to Alberto Bona, Pablo Santurde del Arco and Luca Rosetti! 🔹 In the news, the words of satisfaction from Alberto Bona and our Vice President Antonio Melli: https://lnkd.in/d5R7unaV #IBSA #CaringInnovation #sailingintothefuture #together #sailing IBSA Austria, IBSA France, IBSA Germany, IBSA Italy, IBSA Iberia, IBSA Nordic, IBSA Poland, IBSA Slovakia, IBSA Switzerland | SBO, IBSA UK, IBSA USA
Seventh official place for Alberto Bona at the Transat Québec Saint-Malo
ibsagroup.com
-
How can we move from words to actions to build a truly sustainable future? This is the topic addressed in the sixth IBSA Sustainability Report. In addition to outlining the path to be followed even more incisively, the document highlights the concrete results achieved in the various areas, also thanks to the greater involvement of all subsidiaries and to a growing maturity in the management of ESG (Environmental, Social and Governance) issues. 🔹 Check out our latest news for further details and read the full report: https://lnkd.in/d3zACjp7 #IBSA #CaringInnovation #sustainability
The sixth IBSA Sustainability Report
ibsagroup.com
-
Inclusivity and sustainability are values that IBSA has always supported. It is precisely on these premises that the collaboration (launched in 2021) with the Locarno Film Festival – which this year reached its 77th edition (7-17 August) – is based. Starting last year, IBSA supports the Festival as a Diversity & Inclusion Partner, with the aim of facilitating the participation and enjoyment of film screenings by people with disabilities, cognitive or mental disorders and difficulties due to age. 🔹 Find out all the details in our latest news: https://lnkd.in/dF_xeXA4 #IBSA #CaringInnovation #sustainability #Locarno77
IBSA and the Locarno Film Festival together in 2024
ibsagroup.com
-
The right people and an efficient decision-making process to meet market needs: these are IBSA Poland's strengths. Over the last years the company has been able to position itself as a benchmark in its country, creating a competitive advantage in the Polish market. 🔹 Today, with #IBSAinPerson - Worldwide, we meet Zbigniew Sobala, General Manager of IBSA Poland, who tells us how his adventure with IBSA began, what makes the Polish subsidiary a great company and what our payoff Caring Innovation means to him. #IBSA #CaringInnovation #IBSAstorytelling #WeAreIBSA
-
A new technique developed by researchers at The Sol Goldman Pancreatic Cancer Research Center in Baltimore (USA) could allow PanINs (precancerous pancreatic lesions) to be detected more easily, leading to early diagnosis of pancreatic cancer. 🔹 Find out more in the latest IBSA Foundation for scientific research blog article: https://lnkd.in/dV8YpWRy #IBSA #CaringInnovation #ScienceBeyondFrontiers #IBSAFoundation #pancreaticcancer #medicine #research